These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3603999)

  • 1. Maternally-derived antibodies to porcine parvovirus and their effect on active antibody production after vaccination with an inactivated oil-emulsion vaccine.
    Wrathall AE; Cartwright SF; Wells DE; Jones PC
    Vet Rec; 1987 May; 120(20):475-8. PubMed ID: 3603999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological responses in pigs vaccinated with inactivated porcine parvovirus.
    Joo HS; Johnson RH
    Aust Vet J; 1977 Nov; 53(11):550-2. PubMed ID: 565631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An inactivated, oil-emulsion vaccine for the prevention of porcine parvovirus-induced reproductive failure.
    Wrathall AE; Wells DE; Cartwright SF; Frerichs GN
    Res Vet Sci; 1984 Mar; 36(2):136-43. PubMed ID: 6326214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination of swine with an inactivated porcine parvovirus vaccine in the presence of passive immunity.
    Paul PS; Mengeling WL
    J Am Vet Med Assoc; 1986 Feb; 188(4):410-3. PubMed ID: 3949618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of high titre attenuated canine parvovirus vaccine in pups with maternally derived antibody.
    Burtonboy S; Charlier P; Hertoghs J; Lobmann M; Wiseman A; Woods S
    Vet Rec; 1991 Apr; 128(16):377-81. PubMed ID: 2053262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the efficacy of an inactivated virus vaccine against porcine parvovirus.
    Vannier P; Brun A; Chappuis G; Reynaud G
    Ann Rech Vet; 1986; 17(4):425-32. PubMed ID: 3030182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines.
    Geldhof MF; Van Breedam W; De Jong E; Lopez Rodriguez A; Karniychuk UU; Vanhee M; Van Doorsselaere J; Maes D; Nauwynck HJ
    Vet Microbiol; 2013 Dec; 167(3-4):260-71. PubMed ID: 24041768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Field trials of an inactivated, oil-emulsion porcine parvovirus vaccine in British pig herds.
    Wrathall AE
    Vet Rec; 1988 Apr; 122(17):411-8. PubMed ID: 2839927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a vaccine preventing parvovirus-induced reproductive failure in pigs.
    Pye D; Bates J; Edwards SJ; Hollingworth J
    Aust Vet J; 1990 May; 67(5):179-82. PubMed ID: 2165775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody responses of guinea-pigs, rabbits and pigs to inactivated porcine parvovirus vaccines.
    Joo HS; Molitor TW; Leman AD
    Vet Microbiol; 1984 Feb; 9(1):27-33. PubMed ID: 6719818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of vanishing of maternally derived antibodies of Ungulate protoparvovirus 1 suggests an optimal age for gilts vaccination.
    Gava D; Souza CK; Mores TJ; Argenti LE; Streck AF; Canal CW; Bortolozzo FP; Wentz I
    Trop Anim Health Prod; 2017 Jun; 49(5):1085-1088. PubMed ID: 28470582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration and biological half-life of passively acquired colostral antibodies to porcine parvovirus.
    Paul PS; Mengeling WL; Pirtle EC
    Am J Vet Res; 1982 Aug; 43(8):1376-9. PubMed ID: 7103222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of an inactivated virus vaccine for prevention of porcine parvovirus-induced reproductive failure.
    Mengeling WL; Brown TT; Paul PS; Gutekunst DE
    Am J Vet Res; 1979 Feb; 40(2):204-7. PubMed ID: 464358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of maternally derived immunity on piglets' immune response and protection against porcine circovirus type 2 (PCV2) after vaccination against PCV2 at different age.
    Martelli P; Saleri R; Ferrarini G; De Angelis E; Cavalli V; Benetti M; Ferrari L; Canelli E; Bonilauri P; Arioli E; Caleffi A; Nathues H; Borghetti P
    BMC Vet Res; 2016 May; 12():77. PubMed ID: 27170186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Field trials of an inactivated virus vaccine against porcine parvovirus.
    Castro JM; del Pozo M; Simarro I
    Zentralbl Veterinarmed B; 1992 Jul; 39(5):337-44. PubMed ID: 1325724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced specificity of E
    Meyer D; Loeffen W; Postel A; Fritsche S; Becher P
    Transbound Emerg Dis; 2018 Apr; 65(2):e505-e508. PubMed ID: 29314759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of puppies to canine-origin parvovirus vaccines.
    Carmichael LE; Pollock RV; Joubert JC
    Mod Vet Pract; 1984 Feb; 65(2):99-102. PubMed ID: 6328258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternally derived immunity to canine parvovirus infection: transfer, decline, and interference with vaccination.
    Pollock RV; Carmichael LE
    J Am Vet Med Assoc; 1982 Jan; 180(1):37-42. PubMed ID: 7056660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting the transfer of porcine parvovirus antibodies from sow to piglets.
    Damm BI; Friggens NC; Nielsen J; Ingvartsen KL; Pedersen LJ
    J Vet Med A Physiol Pathol Clin Med; 2002 Nov; 49(9):487-95. PubMed ID: 12489874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of vaccination regimen on the transfer of foot and mouth disease antibodies from the sow to her piglets.
    Francis MJ; Black L
    J Hyg (Lond); 1984 Aug; 93(1):123-31. PubMed ID: 6086746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.